Transcendence of Medicine Regenerative Strategies in the Treatment for Diabetic Foot Ulcers
Received: 16-Jun-2016 / Accepted Date: 12-Jul-2016 / Published Date: 12-Nov-2016 DOI: 10.4172/2476-2253.1000106
Abstract
The Diabetes Mellitus type 2 and one of its complications, the diabetic foot ulcer (DFU), are a great problem of public health that affects millions of people around the world. Due to its complexity, DFUs treatment and handling are expensive and complex. In addition, amputations of lower limbs and death are relatively frequent because conventional treatment cannot avoid them. In other hand, the use of growth factors, 3D scaffolds and mesenchymal stem cells, called regenerative medicine (RM), have created new perspectives about the treatment of this kind of injuries. The RM has demonstrated favorable clinical outcomes not only in the case of DFUs, so that, this new medicine area promises to become an important tool that supports or substitutes to conventional treatment in cases of tissue or organic damage caused by the different chronic and traumatic diseases.
Keywords: Diabetes foot ulcer; Mesenchymal stem cells; Regenerative medicine
6885Introduction
Diabetes mellitus type 2 (DM2) is a great problem of world health that affects to millions of people around the world and it has been anticipated that the number of patients will be increase in the next decades [1]. Some of its complications as peripheral neuropathy and peripheral vascular disease are related to development cutaneous injures in lower limbs that are known like diabetic foot ulcers (DFUs) [2-4]. In addition, due to the generalized inflammatory state, characteristic of this disease, the healing process are affected, causing a slowly and costly recovery [2,5-11].
In spite of current treatments, a great number or people with DFUs will suffer lower limb amputation along its life [2,12], this fact becomes to DFUs as the first cause of non-traumatic amputation in world [13], and if this was not enough, the patient’s lifespan will decrease drastically within first five years after the surgery [9,14-16]. The treatment of DFUs is focus in promote the scarring of wound through different methods, for example; dressings, surgeries, drugs and skin grafts, among others [17-22], also, the therapy should be accompanied by educational health programs and changes in lifestyle. Even though, there are not enough when the problem is severe because it will progressive into amputation [23,24].
In other hand, in the last years it has been increasing the use of growth factors, 3D scaffolds and mesenchymal stem cells [25-31]-this has been called regenerative medicine (RM) [32,33]- for these wounds, where the treatment has had better healing and economical outcomes than conventional therapy [12,34]. A key factor of medicine regenerative’s development was the discovery of mesenchymal stem cells (MSC) by Friednestein et al. [35-37]. In addition to this, subsequent researches have shown the capability of the MSC to autorenew, differentiation, synthesis of extracellular matrix, intercellular signaling, modulation of immune response and not to generation of rejection like others tissues [38-40]. All these characteristics have been crucial to employ the MSC to rebuild tissues and organs [38-53].
In the research made by Benítez-Arvízu et al. [54], strategies of medicine regenerative were implemented by the use of: a) growth factors of platelets [55,56], b) 3D scaffold of skin [57], and c) mesenchymal stem cells of bone marrow [54,58] (Figure 1). This therapy was possible because other researches have demonstrated the benefit of this kind of treatment in similar wounds [12,34,59]. At the same way, after several months of treatment, they could see completely incorporation of the 3D, this without side effects were seen.
Figure 1: A schema about the implementation of medicine regenerative in the patient; firstly, there was necessary to get a skin biopsy (a), bone marrow (b), and peripheral blood (c) of the patient. After these, the elements were processed to obtain; a 3D scaffold (d), plasma rich platelet (e) and bone marrow mesenchymal stem cells (BM-MSCs) (f). As the BM-MSCs, the 3D scaffold was kept in culture conditions on Carrel’s Flask at 37°C, 5% of CO2 and saturated humidity until its use (g). Finally, in completely asepsis at operating room and previously surgical scrubbing, the 3D scaffold was fixed by suture at wound area (i) and the BM-MSCs into the PRP were placed (j).
In many researches have been demonstrated that medicine regenerative strategies in patients were best than conventional therapies, without collateral effects have been seen [30,60-65]. This becomes to RM an important element of support to the treatment in the case of cutaneous wounds with small possibilities of healing [66,67]. It is important to highlight that a good handling of DFUs could avoid more than half of amputations and, of course, this could represented a great save of money and improvements of patients quality life [68-73].
Conclusions
Even though, there are a lot of information about the mesenchymal stem cells biology, there is still very limit the knowledge of the regenerative mechanisms induced by them in patients [74-77]. However, the increasing of clinic trials based in MSC could let us understand better the effect of them in vivo and this will open new scenes to strengthen and valid clinic trials of medicine regenerative a great scale [65,78-81]. This could be a solution by the world health problems that DM2, its complications and other kinds or disease do [82]. Finally, although our expectations about what medicine regenerative can do are huge, there are still a lot of things to do.
Acknowledgments
The authors thank to the Lizbeth G. Diaz-Garcia engineer by the support on figures development. In addition, the researcher H. Diaz- Garcia would like to thank to the Consejo Nacional de Ciencia y Tecnologia of Mexico (CONACyT) by economical support.
References
- Alzahrani H, Ammar H, Alzahrani A, Shoaib H (2013) Healing of chronic diabetic foot ulcers with a skin substitute: Patient selection is the key to success. 天美传媒 Journal of Regenerative Medicine 2: 15-19.
- Jeffcoate WJ, Hardding KG (2003) Diabetic foot ulcers. The Lancet 361: 1545-1551.
- Nettel F, Rodr脙颅guez N, Nigro J, Gonz脙隆lez M, Conde A, et al. (2013) Primer consensolatinoamericano de 脙潞lcerasvenosas. Resumen. Rev MexAng 41: 95-126.
- International Best Practice Guidelines (2013) Wound Management in Diabetic Foot Ulcers. Wounds International.
- S脙隆nchez MB, Mart脙颅nez LC, Garc脙颅a JP, Quezada ML (2000) Ap脙鲁sitoshidrocoloides en 脙潞lcerascr脙鲁nicas de origen vascular de los miembrosinferiores. Rev Fac Med UNAM 43: 130-132.
- Castro G, Liceaga G, Arrioja A, Calleja JM, Espejel A, et al. (2009) Gu脙颅acl脙颅nicabasada en evidenciapara el manejo del pie diab脙漏tico. Med Int Mex 25: 481-526.
- Riazi AM, Kwon SY, Stanford WL (2009) Stem cell sources for regenerative medicine. Methods Mol Biol 482: 55-90.
- Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic Transplants of Bone Marrow. Transplantation 6: 230-47.
- Ar脙漏valo-Romero JA, P脙隆ez-Guerrero DM, Rodr脙颅guez-Pardo VM (2007) C脙漏lulasmadremesenquimales: caracter脙颅sticasbiol脙鲁gicas y aplicacionescl脙颅nicas. NOVA 5: 101-212.
- Chen J, Wang D, Li X, Geng L, Zhang H, Feng X, Sun L (2014) Umbilical-cord derived Mesenchymal Stem Cell Transplantation Ameliorated Severe Leg Ulcers in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature. J Stem Cell Res Ther 4: 169.
- Diaz-Garcia H, Guti脙漏rrez-Iglesias G (2016) Creaci脙鲁n de bancos de c脙漏lulastroncalesmesenquimalesp脙潞blicos en M脙漏xico; tecnolog脙颅a al alcance de lasmanos. Ideas en Ciencia 43. (Enprensa).
- Rodr脙颅guez-Bola脙卤os RA, Reynales-Shigematsu LM, Jim脙漏nez-Ru脙颅z JA, Ju脙隆rez-M脙隆rquez SA, Hern脙隆ndez-脙聛vila M (2010) Costosdirectos de atenci脙鲁nm脙漏dica en pacientes con diabetes mellitus tipo 2 en M脙漏xico: an脙隆lisis de microcosteo. Rev PanamSaludPublica 28: 412-420.
- Sellheyer K, Krahl D (2010) Cutaneous mesenchymal stem cells: status of current knowledge, implications for dermatopathology. J Cutan Pathol 37: 624-634.
Citation: Diaz-Garcia H, Benítez-Arvízu G (2016) Transcendence of Medicine Regenerative Strategies in the Treatment for Diabetic Foot Ulcers. J Cancer Diagn 1:106. DOI: 10.4172/2476-2253.1000106
Copyright: © 2016 Diaz-Garcia H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 3759
- [From(publication date): 0-2016 - Jan 10, 2025]
- Breakdown by view type
- HTML page views: 3049
- PDF downloads: 710
